Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market
Advertisement

Acumen Pharmaceuticals (ABOS) Technical Analysis

Compare
489 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Acumen Pharmaceuticals’s (ABOS) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Acumen Pharmaceuticals is a Buy.
Acumen Pharmaceuticals’s (ABOS) 20-Day exponential moving average is 1.96, while Acumen Pharmaceuticals’s (ABOS) share price is $1.73, making it a Sell.
Acumen Pharmaceuticals’s (ABOS) 50-Day exponential moving average is 1.85, while Acumen Pharmaceuticals’s (ABOS) share price is $1.73, making it a Sell.

Acumen Pharmaceuticals (ABOS) Pivot Points

Nov 16, 2025, 03:58 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.51
1.64
1.73
1.86
1.95
2.08
2.17
Fibonacci
1.64
1.73
1.78
1.86
1.95
2.00
2.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Acumen Pharmaceuticals (ABOS) Moving Averages

Nov 16, 2025, 03:58 AM
Period
Simple
Exponential
MA5
1.87Sell
1.85Sell
MA10
1.93Sell
1.92Sell
MA20
2.04Sell
1.96Sell
MA50
1.80Sell
1.85Sell
MA100
1.59Buy
1.68Buy
MA200
1.38Buy
1.58Buy
Acumen Pharmaceuticals’s (ABOS) 10-Day exponential moving average is 1.92, while Acumen Pharmaceuticals’s (ABOS) share price is $1.73, making it a Sell.
Acumen Pharmaceuticals’s (ABOS) 100-Day exponential moving average is 1.68, while Acumen Pharmaceuticals’s (ABOS) share price is $1.73, making it a Buy.
Acumen Pharmaceuticals’s (ABOS) stock price is $1.73 and Acumen Pharmaceuticals’s (ABOS) 50-day simple moving average is 1.80, creating a Sell signal.
Acumen Pharmaceuticals’s (ABOS) stock price is $1.73 and Acumen Pharmaceuticals’s (ABOS) 100-day simple moving average is 1.59, creating a Buy signal.
Acumen Pharmaceuticals’s (ABOS) stock price is $1.73 and Acumen Pharmaceuticals’s (ABOS) 200-day simple moving average is 1.38, creating a Buy signal.

Acumen Pharmaceuticals (ABOS) Technical Indicators

Nov 16, 2025, 03:58 AM
Name
Value
Implied Action
RSI (14)
40.07
Neutral
STOCH (9,6)
18.39
Buy
STOCHRSI (14)
13.78
Buy
MACD (12,26)
-0.01
Buy
ADX (14)
27.91
Neutral
Williams %R
-98.65
Buy
CCI (14)
-143.06
Buy
ATR (14)
0.17
-
Ultimate Oscillator
42.61
Neutral
ROC
-21.36
Sell
Acumen Pharmaceuticals’s (ABOS) Relative Strength Index (RSI) is 40.07, creating a Neutral signal.
Acumen Pharmaceuticals’s (ABOS) Trend Strength Indicator (ADX) is 27.91, creating a Neutral signal.
Acumen Pharmaceuticals’s (ABOS) Commodity Channel Index (CCI) is -143.06, creating a Buy signal.
Acumen Pharmaceuticals’s (ABOS) Price Rate of Change (ROC) is -21.36, creating a Sell signal.

FAQ

Is ABOS a Buy, Hold, or Sell?
Based on ABOS’s technical indicators, ABOS is a Hold.
    What is ABOS’s RSI (14)?
    ABOS’s RSI (14) is 40.07, which suggests ABOS is a Neutral.
      What is ABOS’s MACD?
      ABOS’s MACD is -0.01, which suggests ABOS is a Buy.
        What is ABOS’s 5-day moving average?
        ABOS’s 5-day moving average is 1.87, which suggests ABOS is a Sell.
          What is ABOS’s 20-day moving average?
          ABOS 20-day moving average is 2.04, which suggests ABOS is a Sell.
            What is ABOS’s 50-day moving average?
            ABOS’s 50-day moving average is 1.80, which suggests ABOS is a Sell.
              What is ABOS’s 200-day moving average?
              ABOS’s 200-day moving average is 1.38, which suggests ABOS is a Buy.
                What is ABOS’s Williams % R (14)?
                ABOS’s Williams % R (14) is -98.65, which suggests ABOS is a Buy.
                  What is ABOS’s CCI (14)?
                  ABOS’s CCI (14) is -143.06, which suggests ABOS is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis